TROG 03.06 and VCOG PR 01-03: The "Timing of androgen deprivation therapy in prostate cancer patients with a rising PSA (TOAD)" collaborative randomised phase III trial

Gillian Mary Duchesne, Julie Bassett, Catherine D'Este, Mark Frydenberg, Leo Ledwich, Jeremy Laurence Millar, Roger L Milne, Rosemary Smith, Nigel Spry, Martin R Stockler, Rodney Syme, Sandra Turner, Keen-Hun Tai, Henry Woo

Research output: Contribution to conferenceAbstract

Original languageEnglish
Pages1-2
Number of pages2
Publication statusPublished - 4 Jun 2015
EventAmerican Society of Clinical Oncology 2015 - McCormick Place, Chicago, United States of America
Duration: 29 May 20152 Jun 2015
Conference number: 51st

Conference

ConferenceAmerican Society of Clinical Oncology 2015
Abbreviated titleASCO 2015
CountryUnited States of America
CityChicago
Period29/05/152/06/15

Cite this

Duchesne, G. M., Bassett, J., D'Este, C., Frydenberg, M., Ledwich, L., Millar, J. L., Milne, R. L., Smith, R., Spry, N., Stockler, M. R., Syme, R., Turner, S., Tai, K-H., & Woo, H. (2015). TROG 03.06 and VCOG PR 01-03: The "Timing of androgen deprivation therapy in prostate cancer patients with a rising PSA (TOAD)" collaborative randomised phase III trial. 1-2. Abstract from American Society of Clinical Oncology 2015, Chicago, United States of America. http://meetinglibrary.asco.org/content/150983-156